Private Equity Optometry Practice Buyers in 2026: Are They Still Buying?
- Right Fit Capital
- Jun 1
- 7 min read
Yes, private equity firms are still buying optometry practices in 2026. The better question is whether they are buying your type of practice, at the valuation you expect, with a deal structure you would actually want to sign.
The market is not frozen. In May 2026, Brightstar Capital Partners announced a strategic investment in Simon Eye, an integrated vision care platform providing optometry, optical, and ophthalmology services across the Mid-Atlantic. Vision Monday’s April-May 2026 private equity coverage described the optical industry as entering a potential rebound year for dealmaking, while also emphasizing preparation, consolidation, and buyer selectivity. At the same time, industry conversations heading into 2026 have been blunt: after the 2025 pullback, buyers are looking harder at EBITDA quality, operational maturity, provider continuity, and real transferability.
That is the 2026 answer for an owner searching for private equity optometry practice guidance: PE interest still exists, but it is more disciplined. Strong practices can still attract serious attention. Practices with messy books, thin margins, owner dependency, declining optical revenue, or unclear transition plans may find that buyer interest is slower, more conditional, or structured in ways that shift risk back to the seller.
Why Private Equity Is Still Interested in Eye Care
Optometry remains attractive because it sits at the intersection of recurring patient demand, optical retail, medical eye care, local relationships, and consolidation opportunity. Many independent practices are still owner-operated. Many markets remain fragmented. For a platform buyer, that creates a path to build regional density, centralize administrative functions, improve purchasing, recruit providers, add medical services, and professionalize operations.
Eye care also has multiple revenue streams. A strong optometry practice may generate value from comprehensive exams, optical sales, contact lenses, specialty lenses, dry eye, medical optometry, referrals, and long-term patient recall. That revenue mix can be compelling when it is well documented and not overly dependent on one doctor’s personal production.
The activity is not limited to pure optometry. The broader eye-care ecosystem remains active across optometry, ophthalmology, optical retail, retina, and integrated platforms. For example, Olympus Partners announced in March 2026 that it had agreed to sell the retina business of EyeSouth Partners for $1.1 billion, with EyeSouth described as an eye-care focused management services organization partnering with ophthalmologists and medical optometrists. That kind of transaction does not mean every independent OD practice will command platform pricing, but it does show that capital is still paying attention to eye care when the asset quality and strategy are clear.
What Changed From the Peak Roll-Up Years
The old version of the market rewarded speed. Many platforms wanted growth, geographic expansion, and add-on volume. That period made some sellers believe any profitable optometry practice would receive aggressive private equity interest.
In 2026, the market is more nuanced. Higher financing costs, platform integration issues, labor pressure, reimbursement complexity, and investor scrutiny have made buyers more careful. A buyer may still like optometry, but they are more likely to ask whether the practice is durable after closing.
That means the headline multiple is not the whole story. Buyers are spending more time on adjusted EBITDA, add-backs, provider schedules, optical trends, payer mix, staff retention, lease terms, equipment needs, compliance, and whether the seller is willing to support a transition. The strongest offers are often reserved for practices that can prove stability rather than simply claim it.
What Private Equity Optometry Practice Buyers Want in 2026
For a private equity optometry practice buyer, the ideal acquisition is not just a clinic with revenue. It is a transferable business with predictable cash flow, a team that can keep operating, and a clear reason the practice fits the buyer’s existing platform.
Common buyer priorities include:
Clean financials: reliable monthly reporting, clear owner compensation, documented add-backs, and minimal personal expenses running through the business.
Durable EBITDA: profit that can survive a transition after paying market compensation for providers and staff.
Stable or growing revenue: consistent exam volume, solid recall, and no unexplained decline in patient visits or optical sales.
Optical performance: healthy capture rate, managed inventory, strong frame and lens margins, and a credible plan for improvement if optical revenue is underperforming.
Provider continuity: associate OD coverage, a seller willing to stay for a reasonable transition, or a realistic recruitment plan.
Low key-person risk: staff, systems, and patient relationships that are not entirely dependent on the selling owner.
Operational maturity: documented workflows, trained employees, modern practice management systems, and low administrative chaos.
Strategic fit: geography, payer mix, service mix, and growth opportunity that match the buyer’s platform strategy.
If your practice is strong in these areas, the market may still be receptive. If several are weak, private equity may still be interested, but the offer may include a lower valuation, more seller financing, a larger earn-out, stricter employment terms, or more contingencies.
Which Optometry Practices Are Most Likely to Get PE Attention?
Private equity-backed buyers tend to prefer practices that are large enough, profitable enough, and stable enough to justify institutional diligence. That does not always require a multi-location platform, but it does require a business that looks like more than a job for one owner.
The practices most likely to attract attention usually have several of these traits:
Meaningful adjusted EBITDA after normalizing owner compensation
Strong optical sales and room to improve optical operations
Multiple exam lanes or capacity to expand production
Associate OD involvement or a seller open to staying post-close
Clean books and a clear explanation of revenue trends
Modern equipment and limited near-term capital expenditure needs
Reliable staff with low turnover
A market where the buyer already has, or wants to build, density
A smaller practice can still be attractive if it fits a buyer’s local strategy. But a single-location office with modest profit, heavy owner dependence, and limited growth infrastructure may be a better fit for an individual OD, a local competitor, or a regional group than for a larger private equity-backed platform.
Why Deal Structure Matters More Than the Headline Price
In 2026, sellers should be careful about comparing offers by price alone. Two offers with the same stated valuation can produce very different outcomes depending on structure.
Key terms to compare include:
Cash at closing: how much of the purchase price is paid immediately.
Deferred payments: whether part of the price is paid later and what conditions must be met.
Earn-outs: whether future payments depend on revenue, EBITDA, retention, or other targets.
Rollover equity: whether the seller keeps equity in the buyer platform and what the realistic upside and risk look like.
Employment agreement: compensation, schedule, term, duties, non-compete, and clinical autonomy after closing.
Working capital and adjustments: whether the purchase price can move based on balance sheet items, inventory, receivables, or closing conditions.
This is where private equity transactions can become confusing for owners. A buyer may present a strong headline number, then build in structure that makes the true outcome depend on post-closing performance. That is not automatically bad, but the seller needs to understand exactly what is guaranteed, what is conditional, and what control they will have after the transaction.
PE Is Not the Only Buyer Path
Even if a private equity-backed buyer is active in your market, it may not be the best fit for your goals. Individual optometrists, regional eye-care groups, strategic acquirers, and local competitors can all be viable buyers depending on the practice.
An individual buyer may preserve local identity and culture. A regional group may understand your market and move efficiently. A larger platform may offer scale, infrastructure, and a more institutional transition. The right answer depends on your valuation expectations, timeline, staff concerns, patient continuity goals, and desired role after closing.
If you are comparing buyer types, Right Fit Capital’s guide to how to find buyers for an optometry practice explains how individual ODs, regional groups, corporate platforms, private equity-backed buyers, and strategic acquirers differ. You can also review whether you need a broker to sell an optometry practice and how a confidential buyer-introduction process compares with a public listing.
How to Prepare Before Speaking With Private Equity
If you want to test the private equity market, prepare before sharing sensitive information. Buyers will quickly form an opinion based on how clearly you can explain the business.
Start with these steps:
Clean up financial reporting. Make sure revenue, cost of goods, payroll, rent, owner compensation, and add-backs are understandable.
Know your adjusted earnings. Do not rely only on revenue. Understand EBITDA or seller’s discretionary earnings after realistic adjustments.
Document provider coverage. Clarify doctor schedules, associate agreements, production by provider, and your willingness to stay after closing.
Review optical metrics. Be ready to discuss capture rate, frame margins, lens mix, inventory practices, and recent trends.
Map transition risks. Identify lease issues, staff dependencies, equipment needs, payer concentration, and any operational gaps before buyers do.
Define your ideal outcome. Decide whether you care most about price, cash at closing, culture, speed, post-sale role, staff retention, or patient continuity.
For valuation context, see Right Fit Capital’s article on what an optometry practice is worth and the optometry valuation calculator. These tools will not replace a real buyer conversation, but they can help frame the questions buyers are likely to ask.
Should You Wait for the Market to Improve?
Some owners are tempted to wait for a stronger M&A market. That may be reasonable if your practice is growing, profitability is improving, and you have the energy to keep building. But waiting only helps if the business becomes more attractive during the waiting period.
If revenue is flat, margins are compressing, the owner is reducing hours, or staff turnover is rising, waiting can work against you. Buyers usually pay for future confidence, not past peak performance. A practice that looked stronger two years ago may not receive the same attention if the most recent numbers tell a weaker story.
A good middle path is to explore the market quietly. You do not need to commit to selling just because you speak with buyers. A confidential process can help you understand which buyer types are realistic, what questions they will ask, and whether the market sees your practice the way you do.
Bottom Line: PE Is Still Buying, but Fit Matters
Private equity is still buying optometry practices in 2026, but the market is more selective than it was during the fastest roll-up years. Strong financials, clean operations, provider continuity, optical performance, and a credible transition plan matter more than ever.
If you are considering a private equity optometry practice sale, do not start by asking only, “What multiple can I get?” Start by asking which buyers would actually want your practice, what risks they would see, what deal structure they would propose, and whether that buyer path matches the future you want for your staff, patients, and personal life.
Right Fit Capital helps optometry practice owners explore buyer options confidentially, compare likely buyer fit, and understand the path from initial conversation to a potential transition. If you are thinking about selling now or simply want to know where your practice stands, visit rightfitcapital.com to start the conversation.
